首页> 外文期刊>Scientific reports. >Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3
【24h】

Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

机译:尼古丁对柯萨奇病毒B3诱发的病毒性心肌炎小鼠模型的剂量依赖性保护作用

获取原文
           

摘要

The alpha 7 nicotinic acetylcholine receptor (alpha7 nAChR) was recently described as an anti-inflammatory target in various inflammatory diseases. The aim of this study was to investigate the dose-related effects of nicotine, an alpha7 nAChR agonist, in murine model of viral myocarditis. BALB/C mice were infected by an intraperitoneally injection with coxsackievirus B3. Nicotine was administered at doses of 0.1, 0.2 or 0.4?mg/kg three times per day for 7 or 14 consecutive days. The effects of nicotine on survival, myocardial histopathological changes, cardiac function, and cytokine levels were studied. The survival rate on day 14 increased in a dose-dependent fashion and was markedly higher in the 0.2 and 0.4?mg/kg nicotine groups than in the infected untreated group. Treatment with high-dose nicotine reduced the myocardial inflammation and improved the impaired left ventricular function in infected mice. The mRNA expressions and protein levels of TNF- α , IL-1 β , IL-6, and IL-17A were significantly downregulated in dose-dependent manners in the nicotine treatment groups compared to the infected untreated group. Nicotine dose-dependently reduced the severity of viral myocarditis through inhibiting the production of proinflammatory cytokines. The findings suggest that alpha7 nAChR agonists may be a promising new strategy for patients with viral myocarditis.
机译:最近,α7烟碱乙酰胆碱受体(alpha7 nAChR)被描述为各种炎症性疾病的抗炎靶标。这项研究的目的是调查病毒性心肌炎的小鼠模型中烟碱(一种α7nAChR激动剂)的剂量相关作用。通过腹膜内注射柯萨奇病毒B3感染BALB / C小鼠。尼古丁以0.1、0.2或0.4?mg / kg的剂量每天给药3次,连续7或14天。研究了尼古丁对存活率,心肌组织病理学变化,心脏功能和细胞因子水平的影响。第14天的存活率呈剂量依赖性,并且在0.2和0.4 mg / kg烟碱组中明显高于未感染组。用大剂量尼古丁治疗可减轻感染小鼠的心肌炎症并改善受损的左心室功能。与未治疗组相比,尼古丁治疗组中TNF-α,IL-1β,IL-6和IL-17A的mRNA表达和蛋白水平呈剂量依赖性显着下调。尼古丁通过抑制促炎细胞因子的产生,剂量依赖性地降低了病毒性心肌炎的严重程度。研究结果表明,α7nAChR激动剂可能是病毒性心肌炎患者的有希望的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号